BioBlogger_

FDA Has Egg On Its Face…Again (NFLD)

I agree with many of the comments to my post. There are certainly two sides to this story. A very interesting fact pointed out by Northfield was that Polyheme patients had, "...60 percent of their blood volume withdrawn versus 30 percent of the control group. In keeping with the protocol, the PolyHeme group also received substantially more fluids than did the controls resulting in complex issues with fluid management in those patients." However, I am still concerned about the safety issues brought up in the article especially in light of the fact the trauma trial does not require patient consent, but in hindsight I do think the WSJ embelished the issues.